GSK Unveils $576M Biopharma Factory Plans to Public
The public will get a chance to find out more about GlaxoSmithKline's plans for a new, state-of-the-art factory in Ulverston, UK at a series of exhibitions later this month.
Visitors will be able to look at the current designs and layouts for the factory and speak to GSK staff and planning experts.
GSK announced plans for a new biopharmaceutical manufacturing facility in March 2012. It will be the company’s first new factory in the UK for almost 40 years.
More information and feedback forms will be available on the GSK Ulverston website